TY - JOUR
T1 - Fasting glycemia in sleep disordered breathing
T2 - Lowering the threshold on oxyhemoglobin desaturation
AU - Stamatakis, Katherine
AU - Sanders, Mark H.
AU - Caffo, Brian
AU - Resnick, Helaine E.
AU - Gottlieb, Dan J.
AU - Mehra, Reena
AU - Punjabi, Naresh M.
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2008/7/1
Y1 - 2008/7/1
N2 - Study Objectives: Commonly used definitions of sleep-disordered breathing (SDB) are based on identifying discrete events of breathing abnormalities during sleep that are accompanied by an oxyhemoglobin desaturation (ΔSaO 2) of at least 4%. However, it is not known whether disordered breathing events with oxyhemoglobin desaturation less than 4% are associated with clinical sequelae such as abnormalities in fasting glycemia. Design: Cross-sectional study. Subjects and Setting: Participants from the Sleep Heart Health Study (SHHS) with a fasting glucose measurement made within a year of the baseline polysomnogram. Measurements and Results: SDB severity was defined using the apnea-hypopnea index (AHI) and the hypopnea index (HI) by counting events with different levels of oxyhemoglobin desaturation (0.0%-1.9%, 2.0%-2.9%, 3.0%-3.9%, ≥4.0%). Fasting glucose levels were used to classify individuals into normal (<100 mg/dL), impaired (100-125 mg/dL), and diabetic (≥126 mg/dL) groups. Ordinal logistic regression was used to determine the adjusted relative odds of an abnormal glucose value across quartiles of the hypopnea index, independent of factors such as age, body mass index, waist circumference, and usual sleep duration. The prevalence of impaired and diabetic fasting glucose in the analytical sample was 32.9% and 5.8%, respectively. The covariate-adjusted relative odds of impaired or diabetic fasting glucose in the highest versus the lowest AHI quartile was 1.35 (95% Cl: 1.04-1.76) for events with a ΔSaO2 ≥ 4.0%, 1.72 (95% Cl: 1.20-2.48) for events with a ΔSaO2 between 3.0%-3.9%, 1.41 (95% Cl: 1.07-1.86) for events with a ΔSaO2 between 2.0%-2.9%, and 1.07 (95% Cl: 0.84-1.37) for events with a ΔSaO2 between 0.0%-1,9%. The corresponding odds ratios for the HI were 1.47 (95% Cl: 1.13-1.92), 2.25 (95% Cl: 1.59-3.19), 1.44 (95% Cl: 1.09-1.90), and 1.15 (95% Cl: 0.90-1.47), respectively. Conclusions: The results of this study indicate that SDB events accompanied by oxyhemoglobin desaturation of between 2% to 4% are associated with fasting hyperglycemia. These findings suggest that milder degrees of SDB may predispose to adverse metabolic outcomes.
AB - Study Objectives: Commonly used definitions of sleep-disordered breathing (SDB) are based on identifying discrete events of breathing abnormalities during sleep that are accompanied by an oxyhemoglobin desaturation (ΔSaO 2) of at least 4%. However, it is not known whether disordered breathing events with oxyhemoglobin desaturation less than 4% are associated with clinical sequelae such as abnormalities in fasting glycemia. Design: Cross-sectional study. Subjects and Setting: Participants from the Sleep Heart Health Study (SHHS) with a fasting glucose measurement made within a year of the baseline polysomnogram. Measurements and Results: SDB severity was defined using the apnea-hypopnea index (AHI) and the hypopnea index (HI) by counting events with different levels of oxyhemoglobin desaturation (0.0%-1.9%, 2.0%-2.9%, 3.0%-3.9%, ≥4.0%). Fasting glucose levels were used to classify individuals into normal (<100 mg/dL), impaired (100-125 mg/dL), and diabetic (≥126 mg/dL) groups. Ordinal logistic regression was used to determine the adjusted relative odds of an abnormal glucose value across quartiles of the hypopnea index, independent of factors such as age, body mass index, waist circumference, and usual sleep duration. The prevalence of impaired and diabetic fasting glucose in the analytical sample was 32.9% and 5.8%, respectively. The covariate-adjusted relative odds of impaired or diabetic fasting glucose in the highest versus the lowest AHI quartile was 1.35 (95% Cl: 1.04-1.76) for events with a ΔSaO2 ≥ 4.0%, 1.72 (95% Cl: 1.20-2.48) for events with a ΔSaO2 between 3.0%-3.9%, 1.41 (95% Cl: 1.07-1.86) for events with a ΔSaO2 between 2.0%-2.9%, and 1.07 (95% Cl: 0.84-1.37) for events with a ΔSaO2 between 0.0%-1,9%. The corresponding odds ratios for the HI were 1.47 (95% Cl: 1.13-1.92), 2.25 (95% Cl: 1.59-3.19), 1.44 (95% Cl: 1.09-1.90), and 1.15 (95% Cl: 0.90-1.47), respectively. Conclusions: The results of this study indicate that SDB events accompanied by oxyhemoglobin desaturation of between 2% to 4% are associated with fasting hyperglycemia. These findings suggest that milder degrees of SDB may predispose to adverse metabolic outcomes.
KW - Glucose metabolism
KW - Sleep-disordered breathing
UR - http://www.scopus.com/inward/record.url?scp=46849107138&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=46849107138&partnerID=8YFLogxK
M3 - Article
C2 - 18652097
AN - SCOPUS:46849107138
SN - 0161-8105
VL - 31
SP - 1018
EP - 1024
JO - Sleep
JF - Sleep
IS - 7
ER -